Loading
Latest filing published 19 Dec 2025 for Eupraxia Pharmaceuticals Inc., €53k. Read the official filing
No signal scores available.
Our data holds just one disclosure by Michael Wilmink, dated 19 December 2025, reporting a share grant worth €53k in Eupraxia Pharmaceuticals Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration